High Falls Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,405
| Closed | -$286K | – | 152 |
|
|
2025
Q3 | $286K | Sell |
3,405
-62
| -2% | -$5.11K | 0.06% | 120 |
|
|
2025
Q2 | $274K | Buy |
3,467
+16
| +0.5% | +$1.27K | 0.06% | 117 |
|
|
2025
Q1 | $310K | Buy |
3,451
+55
| +2% | +$5.13K | 0.07% | 90 |
|
|
2024
Q4 | $338K | Sell |
3,396
-476
| -12% | -$49.1K | 0.08% | 80 |
|
|
2024
Q3 | $440K | Sell |
3,872
-185
| -5% | -$22K | 0.1% | 69 |
|
|
2024
Q2 | $502K | Buy |
4,057
+45
| +1% | +$5.8K | 0.12% | 61 |
|
|
2024
Q1 | $529K | Buy |
4,012
+180
| +5% | +$22.2K | 0.13% | 58 |
|
|
2023
Q4 | $418K | Sell |
3,832
-23
| -0.6% | -$2.39K | 0.11% | 60 |
|
|
2023
Q3 | $397K | Buy |
3,855
+4
| +0.1% | +$431 | 0.12% | 61 |
|
|
2023
Q2 | $444K | Buy |
3,851
+5
| +0.1% | +$568 | 0.13% | 61 |
|
|
2023
Q1 | $409K | Buy |
3,846
+104
| +3% | +$11.2K | 0.12% | 64 |
|
|
2022
Q4 | $415K | Buy |
3,742
+353
| +10% | +$36.1K | 0.13% | 68 |
|
|
2022
Q3 | $292K | Sell |
3,389
-69
| -2% | -$6.16K | 0.1% | 82 |
|
|
2022
Q2 | $315K | Sell |
3,458
-137
| -4% | -$12.1K | 0.1% | 83 |
|
|
2022
Q1 | $295K | Sell |
3,595
-118
| -3% | -$9.3K | 0.08% | 91 |
|
|
2021
Q4 | $285K | Buy |
3,713
+3
| +0.1% | +$239 | 0.07% | 104 |
|
|
2021
Q3 | $279K | Buy |
3,710
+188
| +5% | +$14.3K | 0.08% | 101 |
|
|
2021
Q2 | $274K | Sell |
3,522
-56
| -2% | -$4.17K | 0.07% | 106 |
|
|
2021
Q1 | $263K | Sell |
3,578
-76
| -2% | -$5.61K | 0.08% | 103 |
|
|
2020
Q4 | $285K | Buy |
+3,654
| New | +$279K | 0.08% | 86 |
|
|
2020
Q3 | – | Sell |
-3,642
| Closed | -$269K | – | 70 |
|
|
2020
Q2 | $269K | Buy |
3,642
+144
| +4% | +$10.8K | 0.1% | 74 |
|
|
2020
Q1 | $257K | Buy |
3,498
+7
| +0.2% | +$550 | 0.1% | 68 |
|
|
2019
Q4 | $303K | Buy |
3,491
+101
| +3% | +$8.3K | 0.09% | 79 |
|
|
2019
Q3 | $272K | Sell |
3,390
-1,047
| -24% | -$83.9K | 0.08% | 80 |
|
|
2019
Q2 | $355K | Buy |
4,437
+9
| +0.2% | +$689 | 0.12% | 67 |
|
|
2019
Q1 | $351K | Buy |
4,428
+547
| +14% | +$40.9K | 0.12% | 64 |
|
|
2018
Q4 | $283K | Buy |
3,881
+1
| +0% | +$71 | 0.11% | 56 |
|
|
2018
Q3 | $263K | Sell |
3,880
-2,094
| -35% | -$133K | 0.09% | 72 |
|
|
2018
Q2 | $346K | Buy |
+5,974
| New | +$337K | 0.12% | 70 |
|
|
2017
Q4 | – | Sell |
-3,274
| Closed | -$200K | – | 95 |
|
|
2017
Q3 | $200K | Hold |
3,274
| – | – | 0.08% | 85 |
|
|
2017
Q2 | $200K | Buy |
+3,274
| New | +$199K | 0.08% | 83 |
|
Other funds holding MRK
High Falls Advisors's MRK Position: Q4 2025 in Review
High Falls Advisors sold out of Merck (MRK) in Q4 2025, closing a stake of 3,405 shares — an estimated $286K sold.
High Falls Advisors first reported a position in MRK in Q2 2017 and held it in 31 quarters. The position peaked at $529K in Q1 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- High Falls Advisors reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- High Falls Advisors sold 3,405 Merck shares in Q4 2025, an estimated $286K.
- High Falls Advisors first reported a position in Merck in Q2 2017 and held it in 31 quarters.
- High Falls Advisors's Merck position peaked at $529K in Q1 2024.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on High Falls Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.